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Abstract 
Tokai Optical Company in Okazki, Japan, has developed a new line of 
CR-39 medical lenses designed to manage certain ocular and visual 
disorders. Before these lenses can be incorporated into the medical 
market, it is necessary to verify the selective filtration 
characteristics claimed by Tokai Optical Company. Using a modified 
Varian OMS 200 UV/Visible Spectrophotometer, Tokai Optical 'CC 
Filter' lenses were analyzed and compared to the transmission 
properities published by the manufacturer. It was concluded that 
the spectral transmission results differ by no more than 3.5 percent 
transmittance with the majority being less than 1.0 percent 
difference. The historical use of spectrally selective lenses in the 
treatment, management and prevention of ocular and visual 
disorders is also discussed. 
Introduction 
It is well known that illumination plays a crucial role in 
optimizing useful vision in patients with reduced visual function 
resulting from disease or the aging process. For this reason, 
practitioners prescribe neutral density or selective filtration (S.F.) 
lenses in an attempt to increase patient comfort and visual 
performance. It has also been proposed that by selectively filtering 
specific wavelengths from entering the eye, destructive 
pathological processes may be slowed. 
Tokai Optical Company has developed a series of lenses specifically 
with this in mind. The lenses, presently marketed in Japan, are sold 
under the brand name of "CC Filter" lenses and include two types: CCP, 
and CCP-400, the latter allowing slightly more transmission of the 
visible spectrum. Both are manufactured from a CR-39 resin. Tokai 
medical lenses are available with six different transmission spectra and 
appear red, orange, yellow, light green, dark green, and brown in color. 
All are a fixed tint, and made of non photochromic material. This paper 
attempts to verify the claimed transmission characteristics of Tokai 
medical lenses through careful spectrophotometric analysis. Lenses 
with different transmission characteristics can be used to alleviate 
1 
ocular symptoms. Research on the clinical application of such lenses is 
reviewed and discussed. 
Procedure 
A total of 12 different lenses were verified using a modified 
Varian OMS 200 UV/Visible/IR Spectrophotometer. The substrate 
carrier was modified to allow measurement through plastic lenses 
as the spectrophotometer's primary use is to measure transmission 
characteristics of liquids. Modification entailed the simple removal 
of the carrier such that lenses could be positioned centrally in the 
path of the analyzer. Using the transmission through air as a 100% 
transmittance base line, each lens was scanned from 280 nm to 800 
nm and a printout of the transmission curves was obtained. As well, 
transmissions measured at specific wavelengths, were compared to 
values reported by Tokai Optical Company. These wavelengths 
included 280 nm (harmful UV-C radiation), 315 nm (harmful UV-A 
radiation), 400nm (end of the UV spectrum), 450 nm (scotopic 
sensitivity maximum), 550 nm (photopic sensitivity maximum) and 
850 nm (infrared). These two measuring approaches allowed for 
direct comparisons between the present study's values and those 
reported by Tokai Optical Company. 
Results 
Spectrophotometric analysis of the study lenses revealed only 
minimal deviations from Tokai Optical Company's reported 
transmission characteristics. The lens that differed the greatest 
was the Amber CCP400. At 450 nm, this lens showed 11.4% greater 
absorption than was reported by Tokai Optical Company (Table 1 ). 
Spectrophotometer plots from Tokai Optical Company as well as 
those from the present study can be found in Appendix 1. 
Overall, the average deviation for each CCP lens varied by no 
more than 1.29% between the present study and Tokai Optical 
Company's values. The present study's results revealed both over 
and under-estimation of transmittances reported by Tokai (Figure 1 ). 
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Table 1. 
Percent light transmission of CCP lenses at specific wavelengths 
Colora: Yellow Ora!!9_e __ Red Ll!lht Gr~~ Dark Green Brown I I 
Tokal fUX) % onrerence Tokal PLro % Dnrerence Tokal FUXl % DUference Tokal fUX) % Dlllorence Tokal FUXl % DHference Tokal fUX) % DHierence 
---- --- - - --- ---
-- -----1 
~80 nm 0.16% 0.00% 016% 0 .18% 0 .00% 0 18% 0 .18% 0.00% 0.18% ~:..?_4% 0.00% 0.24% 0.19% 0.00% 0.19% o ,!~~ 0.00% 0.15"1 r---- - - - -
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' 
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(,.) I 
---1------
Percent light transmission of CCP400 lenses at specific wavelengths 
Colore: Amber llohl Green Yellow Green Olive Evergreen 
Tokal FUXl % onrerence Tokal PLro % DHierence Tokal FUXl % DNierence Tokal fUX) % DHierence lokal fUX) % DHierence Tokal fUX) % DHierence 
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Figure 1. Transmission spectra of Tokai Optical CCP lenses. 
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The CCP400 lenses average-percent-difference in transmittance 
did not exceed 3.26% (Table 1 ). Curiously, Tokai Optical Company 
consistently overestimated transmittance relative to the values 
found in the present study. Therefore, Tokai Optical's CCP400 Lenses 
consistently absorbed more radiation than was claimed by the 
Company (Figure 2). 
Discussion 
The present study supports Tokai Optical Companies claimed 
absorption characteristics of their medical lenses. Therefore, these 
lenses can be used for the purposes of their design, without 
hesitation, as they have been shown to perform to the levels claimed 
by the Company. The prescribing practitioner must, however, be 
aware of how patients will benefit from S.F. lenses as well as who 
will be best suited to them. 
There are three proposed benefits from the use of tints and 
filters: (a) enhancement of visual performance in varying 
illuminations, (b) improved visual comfort; and (c) controlling the 
progression of ocular disease. 1 The latter is highly controversial and 
has proven difficult to assess. Patients with cataracts, retinitis 
pigmentosa, diabetic retinopathy, glaucoma, optic nerve atrophy, and 
maculopathies are among those who report improvements in visual 
functioning with S.F. lenes. 2 
Cataracts 
TrokeP. in his investigations into the physical basis for 
transparency of the crystalline lens , concluded that the primary 
basis for visual distortion produced by a cataract was an increase in 
light scattering. This finding is supported in the clinic by observing 
patients with early cataracts or corneal scars. These patients can 
usually read one or two more lines on the Snellen chart if the exam 
room lights are turned down. 4 This is because the room lights act as 
a source of glare thus decreasing the patients contrast sensitivity 
and therefore visual acuity. Neutral density filters will decrease the 
overall illumination entering the eye, reduce the scattering and 
hence increase contrast sensitivity and acuity; similar acuity 
7 
Figure 2. Transmission spectra of Tokai Optical CCP400 lenses. 
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increases can be seen by reducing levels of ambient light. Although 
most of the scattering produced by a cataract or scarred cornea is 
not wavelength dependent, some Raleigh scattering is present. 4 As 
shown in Figure 3., blue light Raleigh scatters approximately nine 
times more than the light we see at our maximum scotopic 
sensitivity level (555 nm, light green). 
Figure 3. Raleigh scattering as a function of wavelength. 
555nm, photopic sensitivity maximum 
i=1/5554 
i=1.05 X 10·11 
320 nm, blue light 
i=1/320 4 
i=9.54 X 1 0· 11 
Therefore, it would be logical that lenses which selectively absorb 
short wavelength light might further benefit the cataract patient. 
However, Bither5 demonstrated that patients with media opacities 
preferred neutral density filters over such S.F. lenses. This finding is 
supported by Chou and Cullen6 who suggested that shorter wavelengths 
only produce slightly more discomfort in situations of very intense 
illumination. Therefore, while Raleigh scattering does contribute to 
glare, more relief might result from reducing total illumination rather 
than selectively filtering high energy light. 
Reducing scattered light, or overall illumination, is not the only 
means by which visual performance can be enhanced in patients with 
media opacities. Tupper4 states that S.F. lenses blocking the blue end of 
the spectrum will sharpen most objects in the real world. He states, for 
example, that yellow-green leaves, red-yellow plants as well as the 
gray-brown branches stand out more vividly against the blue sky. 
Therefore, regardless of light scattering, by using an optical filter that 
absorbs short light wavelengths, the world of colored objects is slightly 
distorted but its contrast can be much enhanced. Practitioners must also 
keep in mind the beneficial effects of reducing incident blue light to help 
slow the progression of cataracts. 
1 1 
Retinitis Pigmentosa 
Retinitis Pigmentosa (R.P.) is a degenerative genetic condition 
resulting in debilitating vision loss. Initially, the R. P. patient loses 
night vision as a result of the initial loss of rod vision, also causing 
the patient to experience tunnel vision .7 This is followed eventually 
by the loss of cone vision. Patients with R.P. very often experience 
difficulties in bright conditions thought to be due to an abnormal 
recovery time after bleaching.2 It has been proposed that extended 
exposure to light, especially high energy short wavelength light, 
might exacerbate pigmentary retinal degeneration's such as R.P. This 
phenomenon was demonstrated by Dowling and Sidman in 19625 . in 
certain pink eyed rats with inherited retinal dystrophy's. Berson8 . 
however, showed through his conclusive studies in long term 
monocular occlusion, that the progression of R.P. did not slow in the 
absence of light . However, because of the known benefits to ocular 
tissue and the many subjective reports of increased comfort, 
practitioners should not hesitate to prescribe S.F. lenses to R.P. 
patients .9 •7 When introduced in 1981, the Corning CPF 550 lens was 
touted as the first filter designed specifically for the R.P. patient. 1 0 
The CPF lens is photochromic, and appears red as it absorbs light in 
the blue end of the spectrum. Morrisette et al. 11 found that 26 out of 
36 R.P. patients who tried this lens accepted it and reported such 
improvements as decreased dark adaptation time, fewer headaches 
and improved visual functioning and comfort when compared to a non 
tinted lens. Lynch and Brilliant. 12. comparing the Corning CPF lens 
(S.F. lens) with Nair neutral density filters, found slight acuity 
increases in 23 out of 30 eyes tested, while no differences in 
contrast sensitivity or adaptation times could be elicited. Silver 
and Lyness 13 , in their study titled "Do retinitis pigmentosa patients 
prefer red photochromic lenses" concluded that most all R.P. 
patients subjectively prefer the use of a filtering lens, however 
there was no evidence that patients preferred a photochromic red 
lens over a fixed red tint. He continued that a significant number of 
patients did prefer the photochromic lenses but just as many 
subjects disliked them and therefore the consciences prescriber 
must have reservations about prescribing any tint without a trial. 
1 2 
Interestingly, it has been shown that neutral density filters actually 
result in a considerable reduction in visual performance (acuity 
measured under different conditions); no reduction in performance 
was demonstrated with S.F. lenses. 1 
Macular degeneration 
Age related macular degeneration (A.R.M.D.) accounts for 9500 
new cases of legal blindness each year in the United States2 and is 
the leading cause of blindness in the Western World. 14 There are 
many reported functional changes associated with A.R.M.D. including: 
glare, reduced contrast sensitivity, reduced acuity and impaired 
color discrimination2 • It is well established that filters will 
decrease incident light thus decreasing amount of scatter and 
associated discomfort. Similarly, it is well established that in many 
conditions, S.F. lenses lead to a subjective increase in comfort and 
performance. Leat et al 1 . studied low vision patients with 17 
presenting conditions and objectively compared differences in 
performance through neutral density filters and S.F. lenses. Leat 
states that while subjective improvements were noted, patients 
suffering from macular or retinal degeneration's tend to benefit the 
least by using filters of any kind. Corning Optical 15 however, states 
that A.R.M.D. patients are the primary users of their S.F. lenses, thus 
suggesting that visual performance or comfort, whether subjective 
or objective, is significantly enhanced through their use. 
Leat 1 · studied objective contrast sensitivities of patients with a 
wide variety of ocular conditions. Performance was evaluated under 
conditions of glare and under normal illumination with neutral 
density filters and a variety of S.F. lenses. Of the 44 subjects taking 
part, less than one-half showed improvement with any filter. She 
concluded that in the glare free conditions, people with posterior 
pole disease, such as maculopathies, retinopathies (diabetic, 
hypertensive) are more representative of the group gaining no 
improvement. Alternatively, anterior eye conditions (albinism, 
coloboma, aniridia, media opacities) are more numerous amongst the 
1 3 
group gaining improvement with S.F. lenses. Similarly under glare 
conditions she reports more improvement was noted with those with 
anterior eye conditions and more improvement was noted with S.F. 
lenses than with neutral density. While there may be a relationship 
between pathological etiology and the preference of a neutral 
density or a S.F. lens, there does not appear to be a correlation 
between etiology and the absorptive properties of the S.F. chosen. 
This was demonstrated in Nguyen and Hoeft's 1994 study on Corning 
blue blocker filters and related pathologies. Their investigation 
demonstrated that there was no correlation between location of the 
ocular pathology and the transmission cutoff point of the S. F. lens 
chosen. 16 
Conclusion: 
Although the potential benefits of S.F. lenses, on comfort and 
visual performance, have long been realized, relatively few 
companies have invested in their production. The present paper 
supports Tokai Optical Companies reported transmittance curves of 
their medical lenses. Results show reported transmissions differed 
from the present study's, by no more than 3.5 percent transmittance 
with the majority differing by less than 1 percent. While some 
trends are evident, in general, research on the benefits derived from 
using such lenses remains uncertain. The reviewed literature 
suggests cataract patients prefer a more neutral density filter 
under normal conditions while in conditions of high glare, some 
selective filtering characteristics proved beneficial. Evidence 
suggests, to increase patient comfort, more emphasis should be 
placed on reducing the total amount of incident light. However, 
because blue light is thought to exacerbate cataract development, 
S.F. lenses would likely be of benefit. 
Patients with retinitis pigmentosa experienced subjective 
improvements in visual comfort and performance with S.F. lenses 
relative to neutral density filters. An objective increase in acuity 
was demonstrated with a significant number of patients with S.F. 
lenses. Literature suggests there is no strong preference for 
photochromic lenses over a fixed tint. Visual performance may 
14 
actually be compromised with the use of a neutral density filter. 
Considering the literature reviewed, R.P. patients may greatly 
benefit from S.F. lenses, both in comfort and acuity. 
Patients suffering from macular degenerative conditions were 
shown to be among the group benefiting the least from any filter in 
normal lighting conditions however, under glare situations, S.F. 
lenses tended to be more beneficial than neutral density lenses. In 
general, people with age related macular degeneration see 
improvement in acuity and contrast sensitivity with increased 
illumination and thus a neutral density filter may be 
contraindicated. 
It must be stressed that the literature reviewed reports trends , 
and in a clinical situation, individuals are likely to vary in their 
preferences when attempting to chose a medical lens. Unless 
patients are having difficulty meeting a desired acuity demand, the 
practitioner should rely more on the patients subjective responses 
rather than objective findings when choosing a medical lens. With 
new lenses entering the market this task may be made more 
difficult but the potential rewards to patients may be tremendous. 
1 5 
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Appendix 1. Spectrophotometer plots of percent transmission versus 
wavelength of Tokai Medical Lenses. 
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